
Pulmonary embolism is the leading cause of maternal death in the developed zzso The clinical diagnosis of pulmonary embolism is particularly challenging in pregnant patients as zzso changes of pregnancy can mimic symptoms of pulmonary embolism or deep zzso zzso Clinical decision and imaging zzso for zzso zzso disease have been proposed in the literature for the general population, but have not undergone zzso validation in pregnant zzso Laboratory evaluation of zzso levels has likewise been established as a viable screening method in the general population but remains controversial in pregnant zzso Regardless of whether zzso levels are used in this population, the zzso must often rely on imaging tests to confirm or exclude a clinical suspicion of pulmonary zzso Additional factors beyond test performance must be weighed during zzso radiation exposure to the fetus and maternal breast zzso the safety of intravenous contrast administration and the diagnostic accuracy of the various testing options so that diagnosis and proper management are not zzso The epidemiology of zzso zzso zzso disease and the different diagnostic methods are zzso with emphasis on the pregnant zzso Finally, a diagnostic imaging zzso is proposed for the evaluation of the pregnant patient when a clinical suspicion of pulmonary embolism zzso 

